Showing results (421-430 of 889) with videos related to

Sort By:
Pageof 89
Drugs in R&D|August 3, 2022
Effectiveness and Safety of Upadacitinib in the Treatment of Moderate-Severe Atopic Dermatitis: A Multicentric, Prospective, Real-World, Cohort StudyAndrea Chiricozzi, Niccolò Gori, Alessandra Narcisi, et al.
Drugs in R&D|May 16, 2020
Intravenous Tramadol is Effective in the Management of Postoperative Pain Following Abdominoplasty: A Three-Arm Randomized Placebo- and Active-Controlled TrialHarold Minkowitz, Hernan Salazar, David Leiman, et al.
Drugs in R&D|December 16, 2025
Pharmacokinetics, Pharmacodynamics, and Safety of ET-26 in Subjects with Mild to Moderate Renal ImpairmentFan Yang, Chao-Zhuang Shen, Pan-Pan Ye, et al.
Drugs in R&D|November 5, 2025
Efficacy and Safety of Ulinastatin in Post-traumatic Sepsis: A Randomized Controlled TrialAo Yang, Rui Liu, Kongbo Lv, et al.
Drugs in R&D|May 13, 2025
Safety Evaluation of Contezolid (MRX-I) Versus Linezolid in Sprague-Dawley RatsLiping Wei, Min Hong, Min Lu, et al.
Drugs in R&D|May 25, 2025
An Exploratory Pharmacogenetic Pilot Study of Two Reverse Transcriptase Inhibitors, Tenofovir Alafenamide Fumarate and Tenofovir Disoproxil FumarateDerek E Murrell, Benjamin C Kennard, Maria E Bertoni, et al.
Drugs in R&D|May 28, 2025
Opinion of the Italian Association of Myology on Ataluren for the Treatment of Nonsense Mutation Duchenne Muscular DystrophyLuca Bello, Pietro Riguzzi, Emilio Albamonte, et al.
Drugs in R&D|June 23, 2025
Demonstrating Bioequivalence for a Lumacaftor Monosubstance Formulation Versus Orkambi® (Lumacaftor/Ivacaftor) in Healthy SubjectsAlexandra Papaelias, Darcy Lidington, Steffen-Sebastian Bolz
Drugs in R&D|June 21, 2025
Pharmacokinetic Comparison of Novel Tablet-in-Tablet and Conventional Ketorolac Tromethamine Tablets in Beagle DogsXiang-Yang Xie, Yuan Zeng, Zhi-Long Chen, et al.
Drugs in R&D|April 25, 2025
Patient-Reported Outcome Measures in Patients with Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis Treated with GP2015, an Etanercept Biosimilar: Results from Two Phase III Studies (EGALITY and EQUIRA)Diamant Thaçi, Sascha Gerdes, Hendrik Schulze-Koops, et al.
Pageof 89